Authorised representative (AR)

ConMed Limited

康明医疗有限公司
Hong Kong MDACS·77 represented devices·25 applicants·Sep 25, 2006Oct 15, 2024
77
Total devices
25
Applicants
2006
First representation
2024
Most recent
AR overview
Bilingual authorised representative information and contact details
Authorised representative (EN)
ConMed Limited
Authorised representative (ZH)
康明医疗有限公司
Phone
28544413
Timeline
First representation
Sep 25, 2006
Most recent
Oct 15, 2024
Risk class distribution
II
7
III
7
IV
63
Applicant partnerships
Top manufacturers represented by this AR
Recent registrations
Latest 15 MDACS listings represented by ConMed Limited
DeviceRisk classApplicantRegistered
Guide Wires
导丝
IVASAHI INTECC CO., LTD
Asahi Intecc
Oct 15, 2024
Stents, Esophageal
食管支架
IIIELLA-CS, s.r.o.
Ella-Cs, S.R.O.
Sep 24, 2024
Stents, Esophageal
食管支架
IIIELLA-CS, s.r.o.
Ella-Cs, S.R.O.
Sep 24, 2024
Occluders, Cardiac Septum
封堵器,心脏隔膜
IVOcclutech GmbH
Occlutech GmbH
Sep 02, 2024
Occluders, Cardiac Septum
封堵器,心脏隔膜
IVOcclutech GmbH
Occlutech GmbH
Sep 02, 2024
Guide Wires
导丝
IVASAHI INTECC CO., LTD
Asahi Intecc
Jun 06, 2024
Occluders
遮挡器
IVOcclutech Tibbi Urunler San.ve Tic Ltd Sti
Occlutech Tibbi Urunler San.ve Tic Ltd Sti
Apr 30, 2024
Catheters, Vascular, Guiding
导管,血管,引导
IVASAHI INTECC CO., LTD.
Asahi Intecc
Apr 18, 2024
Catheters, Vascular, Infusion, Peripheral
导管,血管,输液,外周
IIASAHI lNTECC CO., LTD.
ASAHI lNTECC CO., LTD.
Apr 18, 2024
Occluders, Cardiac Septum
封堵器,心脏隔膜
IVOcclutech GmbH
Occlutech GmbH
Mar 21, 2024
Guide Wires
导丝
IVASAHI lNTECC CO., LTD.
ASAHI lNTECC CO., LTD.
Mar 07, 2024
Catheters, Cardiac
导管,心脏
IVOcclutech GmbH
Occlutech GmbH
Mar 07, 2024
Catheters, Cardiac, Occluder Delivery
导管,心脏,阻塞器输送
IVOcclutech GmbH
Occlutech GmbH
Mar 07, 2024
Stents, Biliary, Metallic, Self-Expanding
支架,胆道,金属,自膨胀
IIIELLA-CS, s.r.o.
Ella-Cs, S.R.O.
Jan 31, 2024
Catheter Introducers, Vascular
导管介绍器,血管
IVOcclutech Tibbi Ürunler San. Ve Tic. Ltd. Şti.
Occlutech Tibbi Ürunler San. Ve Tic. Ltd. Şti.
Jan 23, 2024
About this profile

ConMed Limited serves as the authorised representative for 77 medical devices in Hong Kong's MDACS framework. Analyse applicant partnerships, risk class exposure, and recent regulatory activity to understand their market footprint.